Why Now’s the Time to Add Some Uranium to Your Portfolio post image

In March of 2011, a meltdown occurred at the Fukushima Daiichi Nuclear Power Plant in Japan, following an earthquake and tsunami. The result was the immediate suspension of all of Japan’s nuclear power generation. Because, at the time, the country utilized approximately 15% of global uranium demand – second most after the United States – this decision had a devastating impact on the atomic fuel’s price. The share price of most uranium related equities, such as producers, developers and explorers, followed the drop.

To make matters worse, the reduction of Japanese demand for nuclear fuel was combined with uncertainty from many other influential governments and regulators. Some additional countries suspended their nuclear power programs and Germany and Switzerland even announced their phased exit from nuclear power.

During the second half of 2014 however, the first positive signs emerged for the nuclear power industry as Japan made progress towards restarting the first two of its 48 idled but operational reactors. The country’s Nuclear Regulation Agency (NRA) recently approved the restart of two reactors located at Sendai, and applications for re-start of 18 more reactors have been [click to continue…]

96% of Patients Experience NO Recurrence of Brain Cancer After IsoRay Treatment post image

IsoRay, Inc. (ISR – $1.76), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of cancers of the prostate, brain, lung, head and neck and gynecological, announced exceptional results conducted by researchers at the Barrow Neurological Institute, one of the world’s foremost brain cancer research and treatment sites.

The Barrow study reported on 27 patients who had a variety of deadly brain cancers. The patients had received as many as four earlier treatments that had failed, resulting in a recurrence of their cancers in the same locations that previously had been treated.

This time, oncologists employed a different technique on these patients. Following surgical removal of the tumor tissue, Cesium-131 was delivered to the targeted brain tissue using a modular, pre-commercial biocompatible carrier system that provided custom-tailored implants for each patient.

The patients fared better than they had using earlier, conventional treatment. In fact [click to continue…]

MCW Energy Moving Towards Production – Significant Expansion Plans Unveiled post image

MCW Energy Group’s (TSXV:MCW – $1.18 & OTCQB:MCWEF – $1.00) exceptional news of its groundbreaking oil sands extraction facility reaching commercial production is spreading like wildfire!

First, a piece titled “Cleaner Oil Sands…A New Extraction Process…” appeared in a special “The Year Ahead” Energy section of Bloomberg’s Business Week print and online editions. The article focused on MCW’s average production cost of $35 USD per barrel as compared to the much higher average cost of crude oil.

And a couple of days later, an article was published by CBS Money Watch, titled “A Cleaner Way To Get Petroleum Out of Oil Sands“, which describes MCW’s unique oil sands extraction technology.

Thanks to all the media attention, the Company’s stock price skyrocketed in a matter of days from $0.90 to [click to continue…]

Cryoport Significantly Expands Sales and Becomes Provider of Choice for “Big Three” Carriers post image

Time for an update on Cryoport Inc (CRYX – $0.44), which provides cryogenic logistics solutions to the life sciences industry. The Company’s liquid nitrogen dry vapor shippers are validated to maintain a constant -150°C temperature for a 10-plus day dynamic shipment duration, and its Cryoportal Logistics Management Platform assists in managing the entire shipment process, including initial order input, document preparation, customs documentation and clearance, courier management, shipment tracking, issue resolution, and delivery.

Temperature sensitive storage and cold chain logistics in the medical and biosciences industries have existed for many years. In most cases, dry ice (carbon dioxide chilled to minus 80 degrees Celsius) is used as a coolant, which has several drawbacks. First, it doesn’t reach the cryogenic level of minus 136 degrees Celsius at which all biological activity ceases. Second, it doesn’t evaporate uniformly, leaving uneven temperatures in the materials. And third, because of the evaporation, someone must physically replenish it every two or three days en route. Cryoport eliminates [click to continue…]

American Power Group On Route To Profitability post image

American Power Group (APGI – $0.40) provides a cost-effective, patented natural gas conversion technology for vehicular, stationary and off-road mobile diesel engines. The Company’s dual-fuel technology is a non-invasive system that enables engines to run on diesel fuel together with either liquefied natural gas, compressed natural gas, pipeline or well-head gas, and bio-methane, with the flexibility to return to 100% diesel fuel operation at any time.

The proprietary technology seamlessly displaces up to 75% of the normal diesel fuel consumption with the average displacement ranging from 40% to 65%. The energized fuel balance is maintained with a proprietary read-only electronic controller system ensuring the engines operate at original equipment manufacturers’ specified temperatures and pressures.

Installation on a wide variety of engine models and end-market applications requires no engine modifications unlike with the more expensive invasive fuel-injected systems in the market. The unit has been approved for six [click to continue…]

Noble Roman’s Not Growing Fast Enough? post image

Noble Roman’s, Inc. (NROM – $1.63), the franchisor and licensor of several pizza concepts reached revenues of $2.1 million in the third quarter ending September 30, 2014, an increase of 9% compared with sales of $1.9 million in the third quarter last year. Net income in the third quarter of 2014 picked up nicely to $499,000, or $0.03 per share, compared with $402,000, or $0.02 per share, in the third quarter last year.

Net sales for the nine months ended September 30, 2014 were $6.1 million, compared to $5.8 million in the same period in 2013, an increase of 5%. Net income for the nine months, ended September 30, 2014 was $1.44 million, or $0.07 per share, compared to $1.30 million, or $0.07 per share in the comparable period last year.

Operating margins were 40.7% in the third quarter of 2014 compared to 39.0% in the third quarter of 2013. [click to continue…]

LiqTech Resumes Profitability After Provital Acquisition post image

Thanks to the acquisition of Provital Solutions, a few months ago, LiqTech International (LIQT – $1.27), the clean technology company that manufactures and markets highly specialized filtration products and systems, was able to announce its first profitable quarter since Q1 2012.

Net sales for the three months ended September 30, 2014 were $4.93 million, compared to $2.95 million for the same period in 2013, an increase of $1.98 million or 67%. This strong performance is primarily driven by higher sales of liquid membranes, including Provital filtration systems (up $1.85 million as compared to last year), and higher Diesel Particulate Filter sales (up $133,000). Net income for the quarter ended September 30, 2014 was $348,000, compared to a net loss of $904,000 in the same period last year, representing an improvement of $1.25 million.

Gross profit margin increased to 29.8% in the third quarter this year, compared to 9.3% for the same period last year.

Net sales for the nine months ended September 30, 2014 were [click to continue…]